Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter

S. J Connolly, H. J.G.M Crijns, C Torp Pedersen, M van Eickels, C Gaudin, R. L Page, S. H Hohnloser and for the ATHENA Investigators

Circulation 120 ( 13 ): 1174 - 1180 , 2009